Silverarc Capital Management, LLC Portfolio Holdings

Silverarc Capital Management, LLC

  • $416 Million
  • Q4 2024

Silverarc Capital Management, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $416 Million distributed in 61 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $31.3M, Merus N.V. with a value of $28.6M, Insmed Inc with a value of $25.7M, Verona Pharma PLC with a value of $24M, and Akero Therapeutics, Inc. with a value of $20.6M.

Examining the 13F form we can see an increase of $14M in the current position value, from $402M to 416M.

Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $416 Million
Healthcare: $416 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 61
  • Current Value $416 Million
  • Prior Value $402 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 34 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email